Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1133.00 -27.95 (2.41%)
Previous Close $1160.95    52 Week High $88.16 
Open $1165.00    52 Week Low $67.88 
Day High $1169.99    P/E 262.27 
Day Low $1132.81    EPS $4.32 
Volume 2,435,340